Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients

NCT01568047 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Placebo
DRUG: BIA 9-1067
DRUG: BIA 9-1067
DRUG: BIA 9-1067
DRUG: Levodopa/Carbidopa
DRUG: Levodopa/Benzerazide

Sponsor

Bial - Portela C S.A.